AlloVir
Morana Jovan-Embiricos is a Managing Partner at F2 Ventures, bringing extensive experience in the venture capital sector. Previously, Morana served as a Venture Partner at MPM Capital from July 2000 to July 2005. Morana holds a PhD in Chemistry from the University of Cambridge.
This person is not in the org chart
This person is not in any offices
AlloVir
AlloVir, formerly ViraCyte, was founded in 2013 and is the leader in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.